COMMUNIQUÉS West-GlobeNewswire

Calithera Biosciences Completes Patient Enrollment in Randomized Phase 2 ENTRATA Trial of Telaglenastat (CB-839) and Everolimus in Renal Cell Carcinoma
04/02/2019
Top line results expected in second half of 2019 SOUTH SAN FRANCISCO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering [...]
CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical
04/02/2019
Drug development veteran to focus on advancing the company’s preclinical portfolio of programs in naturally optimized mRNA TÜBINGEN, Germany and BOSTON, Feb. 04, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated [...]
Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting
04/02/2019
Results from Phase III pivotal studies to be featured at Late-Breaking Research Program on March 2, 2019 BUFFALO, N.Y., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company [...]
Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019
04/02/2019
WALTHAM, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Optinose Announces License Agreement
04/02/2019
YARDLEY, Pa., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and [...]
EyePoint Pharmaceuticals Announces U.S. Commercial Launch of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
04/02/2019
- YUTIQ Indicated for the Treatment of Chronic Non-Infectious Posterior Segment Uveitis - WATERTOWN, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a specialty biopharmaceutical [...]
Northeast Scientific celebrates medical device remanufacturing success with a major reinvestment to bring its marketing, sales and customer service in-house
04/02/2019
WATERBURY, Conn., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Northeast Scientific, Inc. (NES), known for its advanced medical device remanufacturing successes for more than 13 years, continues its business growth and development [...]
Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference
04/02/2019
NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Radient Technologies Inc. Receives Standard Processing License from Health Canada
04/02/2019
EDMONTON, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce it has received its Standard Processing License from [...]
Spero Therapeutics Announces FDA Acceptance of IND Application for SPR994
04/02/2019
CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Canopy Rivers Announces Completion of $17 Million Financing for Its Italian Hemp Platform - Canapar
04/02/2019
TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) is pleased to announce that it has completed a subsequent $9.4 million equity investment in its portfolio [...]
Radient Technologies Inc. Announces Changes to its Board of Directors and Provides Corporate Update
04/02/2019
EDMONTON, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) announces today the following changes to its Board of Directors. The Company [...]
Evolus to Hold Conference Call Following Jeuveau™ FDA Approval
04/02/2019
Conference Call Scheduled for at 8:00am ET / 5:00am PT NEWPORT BEACH, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), today announced that members of management will host a conference call today, [...]
Fennec Pharmaceuticals Announces $12.5 Million Debt Financing With Bridge Bank
04/02/2019
RESEARCH TRIANGLE PARK, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of [...]
Crescita Therapeutics Inc.™ and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra’s Dermatology Product Portfolio
04/02/2019
LAVAL, Quebec, and ORLEANS, Ontario, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Crescita Therapeutics Inc. ("Crescita") (TSX: CTX), a Canadian commercial dermatology company and Tetra Natural Health (NHP), a subsidiary of Tetra [...]
Orion intents to start an open label extension study to the REFALS phase 3 trial studying the effect of oral levosimendan in patients with ALS
04/02/2019
Orion Corporation Press release 4 February 2019 at 10.00 a.m. EET Orion intents to start an open label extension study to the REFALS phase 3 trial studying the effect of oral levosimendan in patients with ALS Orion [...]
Aino Health AB (publ): Aino Health's solution go-live for Multi Contact GmbH
04/02/2019
2019-02-04 Aino Health go-live with its SaaS solution Aino HealthManager for Multi Contact's operations in Germany. This is a joint implementation project with MultiContact and Aino Health that is comprised of process [...]
Aino Health AB (publ): Aino Health's solution go-live for Multi Contact GmbH
04/02/2019
2019-02-04 Aino Health go-live with its SaaS solution Aino HealthManager for Multi Contact's operations in Germany. This is a joint implementation project with MultiContact and Aino Health that is comprised of process [...]
Aino Health AB (publ): Aino Health's solution go-live for Multi Contact GmbH
04/02/2019
2019-02-04 Aino Health go-live with its SaaS solution Aino HealthManager for Multi Contact's operations in Germany. This is a joint implementation project with MultiContact and Aino Health that is comprised of process [...]

Pages